Clinical trials

  • OBEROTATUG RAVTANSINE for CD205-positive recurrent/metastatic solid tumors | Non-small cell lung cancer | Gastric cancer | Endometrial cancer | Ovarian cancer | Breast cancer | Urothelial carcinoma | Cervical cancer | Esophageal cancer | Clear cell renal cell carcinoma | Adenoid cystic carcinoma
  • TASQUINIMOD for Myelofibrosis|Primary myelofibrosis|Post-polycythaemia vera myelofibrosis|Post-essential thrombocythemia myelofibrosis
  • Amlodipine; Irbesartan for Arterial Hypertension | High blood pressure
  • dapagliflozin for Acute myocardial infarction | Heart failure
  • DEXAMETHASONE SODIUM PHOSPHATE for Anterior cruciate ligament rupture | Anterior cruciate ligament reconstruction
  • 7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE HYDROCHLORIDE for Primary myelofibrosis | Secondary myelofibrosis
  • PERFLUTREN for Glioblastoma (IDH wild-type)
  • Autologous enriched T cells retrovirally transduced to express two chimeric antigen receptors targeting CD19 and CD22 for Secondary malignancy following CAR T-cell therapy|Acute lymphoblastic leukemia|Non-Hodgkin's lymphoma|Systemic lupus erythematosus
  • 177LU-RHPSMA-10.1 for Metastatic castration-resistant prostate cancer
  • Tremelimumab for Non-small cell lung cancer
  • donepezil hydrochloride for Anorexia nervosa
  • ART0380 MESILATE (alnodesertib) for Advanced or metastatic solid tumours